Support our Foundation of Myology project
1722 news items
Point mutations in the PABPN1 gene in OPMD are no longer the domain of Europe
On 16/09/2021
Oculopharyngeal muscular dystrophy (OPMD) is a muscular disease of very late onset, most often after the age of fifty, and which mainly results in slowly…
The REDs team supports the International Myotonic Dystrophy Awareness Day
On 15/09/2021
Today, September 15, 2021, marks the first International Myotonic Dystrophies Awareness Day. Objective: to highlight these rare diseases to improve diagnosis, care and support, but…
It’s not just sarcopenia after 65!
On 13/09/2021
Sarcopenia is defined as a slowly progressive loss of diffuse muscle mass and strength with age. It is the visible part of genuine neuromuscular disease…
FKRP-related dystroglycanopathies: preclinical development of autologous cell therapy using a “universal” CRISPR / Cas9 approach
On 09/09/2021
Exon 4 of the FKRP gene alone contains the entire coding sequence for the protein. An American team has developed a CRISPR-Cas9 approach to replace…
A Chinese study on the natural history of paediatric LAMA2 muscular dystrophy
On 08/09/2021
A Chinese multicentre study (covering 9 regions) describes the clinical course and phenotype-genotype correlations of a cohort of children with LAMA2 muscular dystrophy, 116 congenital forms with…
Epilepsy: a central symptom in muscular dystrophies associated with LAMA2?
On 08/09/2021
An Italian team carried out a systematic review of the literature on the subject of “epilepsy and muscular dystrophies linked to LAMA2”, the results are…
The prevalence of non-hereditary rod-shaped myopathy in adults is arguably underestimated
On 08/09/2021
The nemaline-myopathies are well known to pediatricians because of a revelation most often neonatal or in the first months of life. However, it is also…
M&M’s – Muscle Monday Seminar – 13 September – Charlotte A. Peterson (UK)
On 07/09/2021
Novel roles for satellite cells in muscle adaptation and aging Monday September 13th 2021 from 4pm to 5pm Charlotte A. Peterson (Joseph Hamburg Endowed Professor, Director…
When the ERK1/2 pathway disrupts the sarcomere and impairs muscle strength
On 06/09/2021
Emery-Dreifuss muscular dystrophy is characterised by skeletal muscle loss and weakness, associated with dilated cardiomyopathy and cardiac conduction disorders. Although the genetic cause of this…
Efgartigimod reaches phase III in myasthenia gravis
On 06/09/2021
A disorder affecting the neuromuscular junction, Efgartigimod reaches phase III in myasthenia gravis has benefited from relatively intensive therapeutic research for a rare disease, with…
Symptom or not, family history or not, hyperCKemia in a girl should lead to search for a muscular dystrophy
On 03/09/2021
Hereditary neuromuscular diseases are a common cause of persistent hyperCKemia. Duchenne and Becker muscular dystrophies (DMD, DMB), linked to mutations in the DMD gene, are…
A German study clarifies the risk and contraindications of cardiovascular drugs in Myasthenia gravis
On 03/09/2021
Myasthenia gravis is caused by the deleterious action of antibodies produced by the individual and directed against one or more components of the neuromuscular junction.…
Assessment of energy metabolism and blood flow by NMR during and after exercise
On 01/09/2021
Interview with Alfredo Lopez Kolkovsky, researcher from the NMR Imaging and Spectroscopy Laboratory at the Neuromuscular Investigation Centre of the Institute of Myology, jointly managed…
Hope, an exceptional dance gala for the benefit of research excellence
On 01/09/2021
On October 21, at 8:30 p.m., the Casino de Paris will host an exceptional show for the benefit of the Institute of Myology, a research…
M&M’s – Muscle Monday Seminar – 6 September – Adam J. Engler (USA)
On 31/08/2021
Age-dependent Cardiac Dysfunction as a Mechanical Disease Monday September 6th 2021 from 4pm to 5pm Adam J. Engler (Professor and Vice-Chair of Bioengineering at UC San…
The existence of variant triplets within the CTG repeats alleviates the severity of Steinert’s disease without affecting the effectiveness of cognitive behavioral therapy
On 31/08/2021
A genetic analysis carried out in 250 people with Steinert’s disease (DM1) and who participated in the OPTIMISTIC study showed that 21 of them had…
Beneficial effect of gene therapy in model mice of LGMD R1 linked to calpain
On 31/08/2021
Six gene therapy programs are under development in girdle myopathies (LGMD) at Sarepta Therapeutics, in collaboration with the Nationwide Chidren’s Hospital (Columbus, USA). They concern…
A population study quantifies the weight of genes in the occurrence of myositis
On 30/08/2021
Inflammatory myopathies (or idiopathic myositis) seem to arise, like other autoimmune diseases, on a predisposing genetic background. To assess the weight of genes, a team…
Duplications of the SMN1 gene are associated with certain pathologies of the motor neuron
On 25/08/2021
The SMN locus, located in humans in the 5q region, is the site of relative genomic copy number instability of two paralogous genes called SMN1…
The first Solve-RD report confirms the benefit of an exceptional European research project focusing on rare diseases
On 23/08/2021
More than 300 experts from 15 countries, including clinical practitioners, geneticists, patient representatives and researchers, are taking part in the Solve-RD research project, funded by European Union…
